According to the data from 2025, some 16 percent of respondents said that rising health care costs were the most important health issue facing the United States. Cancer ranked second on the list with 15 percent. Issues with healthcare costsCurrently, the most urgent problem facing American healthcare is the high costs of care. The high expense of healthcare may deter people from getting the appropriate treatment when they need medical care or cause them to completely forego preventative care visits. Many Americans reported that they may skip prescription doses or refrain from taking medication as prescribed due to financial concerns. Such health-related behavior can result in major health problems, which may raise the long-term cost of care. Inflation, medical debt, and unforeseen medical expenses have all added to the burden that health costs are placing on household income. Gun violence issueThe gun violence epidemic has plagued the United States over the past few years, yet very little has been done to address the issue. In recent years, gun violence has become the leading cause of death among American children and teens. Even though more than half of Americans are in favor of tougher gun control regulations, there is little political will to strongly reform the current gun law. Gun violence has a deep traumatic impact on survivors and society, it is developing into a major public health crisis in the United States.

A 2024 survey found that over half of U.S. individuals indicated the cost of accessing treatment was the biggest problem facing the national healthcare system. This is much higher than the global average of 32 percent and is in line with the high cost of health care in the U.S. compared to other high-income countries. Bureaucracy along with a lack of staff were also considered to be pressing issues. This statistic reveals the share of individuals who said select problems were the biggest facing the health care system in the United States in 2024.

A survey of adults in the United States found that around ** percent of respondents identified mobility issues, cancer, and cognitive decline as their top aging-related health concerns. This statistic depicts the percentage of adults in the United States who had select health concerns related to the aging process as of 2024.

According to the data from January 2024, 22 percent of respondents said that rising health care costs were the most important health issue facing the United States. Mental health ranked second on the list with 15 percent. Issues with healthcare costsCurrently, the most urgent problem facing American healthcare is the high costs of care. The high expense of healthcare may deter people from getting the appropriate treatment when they need medical care or cause them to completely forego preventative care visits. Many Americans reported that they may skip prescription doses or refrain from taking medication as prescribed due to financial concerns. Such health-related behavior can result in major health problems, which may raise the long-term cost of care. Inflation, medical debt, and unforeseen medical expenses have all added to the burden that health costs are placing on household income. Gun violence issueThe gun violence epidemic has plagued the United States over the past few years, yet very little has been done to address the issue. In recent years, gun violence has become the leading cause of death among American children and teens. Even though more than half of Americans are in favor of tougher gun control regulations, there is little political will to strongly reform the current gun law. Gun violence has a deep traumatic impact on survivors and society, it is developing into a major public health crisis in the United States.

The New York Times is releasing a series of data files with cumulative counts of coronavirus cases in the United States, at the state and county level, over time. We are compiling this time series data from state and local governments and health departments in an attempt to provide a complete record of the ongoing outbreak.

Since the first reported coronavirus case in Washington State on Jan. 21, 2020, The Times has tracked cases of coronavirus in real time as they were identified after testing. Because of the widespread shortage of testing, however, the data is necessarily limited in the picture it presents of the outbreak.

We have used this data to power our maps and reporting tracking the outbreak, and it is now being made available to the public in response to requests from researchers, scientists and government officials who would like access to the data to better understand the outbreak.

The data begins with the first reported coronavirus case in Washington State on Jan. 21, 2020. We will publish regular updates to the data in this repository.

This data package contains dataset on prevalence rates of health conditions and diseases like obesity, diabetes and hearing loss and health risk factors for diseases like tobacco, alcohol and drug use.

This survey displays the share of people in Virginia about what they think is the most important health issue faced in their state, as of April 2022. As much as 38 percent of the survey respondents believed that drug use, the opioid epidemic, or substance abuse are the most important health issue being faced by the people of Virginia.

Changelog:

Update September 20, 2021: Data and overview updated to reflect data used in the September 15 story Over Half of States Have Rolled Back Public Health Powers in Pandemic. It includes 303 state or local public health leaders who resigned, retired or were fired between April 1, 2020 and Sept. 12, 2021. Previous versions of this dataset reflected data used in the Dec. 2020 and April 2021 stories.

Overview

Across the U.S., state and local public health officials have found themselves at the center of a political storm as they combat the worst pandemic in a century. Amid a fractured federal response, the usually invisible army of workers charged with preventing the spread of infectious disease has become a public punching bag.

In the midst of the coronavirus pandemic, at least 303 state or local public health leaders in 41 states have resigned, retired or been fired since April 1, 2020, according to an ongoing investigation by The Associated Press and KHN.

According to experts, that is the largest exodus of public health leaders in American history.

Many left due to political blowback or pandemic pressure, as they became the target of groups that have coalesced around a common goal — fighting and even threatening officials over mask orders and well-established public health activities like quarantines and contact tracing. Some left to take higher profile positions, or due to health concerns. Others were fired for poor performance. Dozens retired. An untold number of lower level staffers have also left.

The result is a further erosion of the nation’s already fragile public health infrastructure, which KHN and the AP documented beginning in 2020 in the Underfunded and Under Threat project.

Findings

The AP and KHN found that:

• One in five Americans live in a community that has lost its local public health department leader during the pandemic
• Top public health officials in 28 states have left state-level departments ## Using this data To filter for data specific to your state, use this query

To get total numbers of exits by state, broken down by state and local departments, use this query

Methodology

KHN and AP counted how many state and local public health leaders have left their jobs between April 1, 2020 and Sept. 12, 2021.

The government tasks public health workers with improving the health of the general population, through their work to encourage healthy living and prevent infectious disease. To that end, public health officials do everything from inspecting water and food safety to testing the nation’s babies for metabolic diseases and contact tracing cases of syphilis.

Many parts of the country have a health officer and a health director/administrator by statute. The analysis counted both of those positions if they existed. For state-level departments, the count tracks people in the top and second-highest-ranking job.

The analysis includes exits of top department officials regardless of reason, because no matter the reason, each left a vacancy at the top of a health agency during the pandemic. Reasons for departures include political pressure, health concerns and poor performance. Others left to take higher profile positions or to retire. Some departments had multiple top officials exit over the course of the pandemic; each is included in the analysis.

Reporters compiled the exit list by reaching out to public health associations and experts in every state and interviewing hundreds of public health employees. They also received information from the National Association of City and County Health Officials, and combed news reports and records.

Public health departments can be found at multiple levels of government. Each state has a department that handles these tasks, but most states also have local departments that either operate under local or state control. The population served by each local health department is calculated using the U.S. Census Bureau 2019 Population Estimates based on each department’s jurisdiction.

KHN and the AP have worked since the spring on a series of stories documenting the funding, staffing and problems around public health. A previous data distribution detailed a decade's worth of cuts to state and local spending and staffing on public health. That data can be found here.

Attribution

Findings and the data should be cited as: "According to a KHN and Associated Press report."

Is Data Missing?

If you know of a public health official in your state or area who has left that position between April 1, 2020 and Sept. 12, 2021 and isn't currently in our dataset, please contact authors Anna Maria Barry-Jester annab@kff.org, Hannah Recht hrecht@kff.org, Michelle Smith mrsmith@ap.org and Lauren Weber laurenw@kff.org.

Big Data Analytics in Healthcare Market Outlook

The global market size for Big Data Analytics in Healthcare was valued at approximately USD 34 billion in 2023 and is anticipated to grow at a robust CAGR of 11.9%, reaching an estimated USD 90 billion by 2032. This remarkable growth is driven by the increasing adoption of data-driven decision-making processes within the healthcare sector, spurred by the mounting pressure to enhance operational efficiencies, improve patient outcomes, and reduce overall healthcare costs. The integration of big data analytics within healthcare systems is enabling organizations to leverage vast amounts of data, leading to enhanced patient care and streamlined operations.

A significant growth factor fueling the expansion of the big data analytics market in healthcare is the ever-increasing volume of data generated by healthcare systems. With the surge of electronic health records, wearable health devices, and various other digital health technologies, the volume of data being generated is unprecedented. This data, if analyzed correctly, holds the potential to transform healthcare delivery models, allowing for more precise diagnostics, personalized treatment plans, and proactive disease management strategies. Consequently, healthcare organizations are increasingly investing in big data analytics tools to harness this data for clinical and operational improvements.

Another key driver of market growth is the growing emphasis on value-based care and the need for healthcare providers to demonstrate high-quality patient outcomes. Value-based care models require providers to focus on the quality rather than the quantity of care delivered, inherently demanding the use of advanced analytics to derive actionable insights from patient data. Big data analytics facilitates the identification of patterns and trends that can lead to improved treatment effectiveness and patient satisfaction. This shift in care models is prompting healthcare organizations to integrate sophisticated analytics solutions that help in predictive modeling, trend analysis, and real-time decision-making, further propelling market expansion.

Additionally, the increasing incidence of chronic diseases worldwide is driving the need for more efficient healthcare services. Big data analytics in healthcare can play a critical role in managing chronic diseases by enabling preventive care and personalized treatment plans. By analyzing patient data, including historical health records, genetic information, and lifestyle choices, healthcare providers can predict potential health issues and intervene early, thereby improving patient outcomes and reducing healthcare costs. This capability is essential in managing the global burden of chronic diseases, thereby boosting the adoption of big data analytics solutions in the healthcare sector.

Regionally, North America dominates the market due to the presence of advanced healthcare infrastructure, the availability of technologically advanced products, and the high adoption rate of healthcare IT solutions. The region's robust regulatory environment and substantial investments in healthcare IT make it a fertile ground for the growth of big data analytics solutions. However, the Asia Pacific region is expected to exhibit the highest growth rate during the forecast period, driven by increasing government initiatives supporting the digitization of healthcare, burgeoning healthcare infrastructure, and a growing focus on precision medicine. The integration of big data analytics in healthcare across diverse regions is indicative of its global importance in optimizing healthcare delivery and patient care.

Component Analysis

In the realm of big data analytics in healthcare, the component segment is vitally instrumental to the market's evolution and includes software and services. Software solutions are the backbone of big data analytics, providing healthcare organizations with the necessary tools to collect, process, and analyze vast datasets. These solutions encompass data management and analytical platforms, which are indispensable for extracting actionable insights from disparate data sources. The software component is continually evolving with advancements in artificial intelligence and machine learning, which enhance data analytics capabilities. Moreover, the increasing demand for user-friendly, customizable software solutions is driving innovation and growth within this segment.

The services component, on the other hand, plays a critical role in the implementation and maintenance of big data analytics solutions. This component includes cons

We asked U.S. consumers about "Prevalence of health conditions" and found that "Mental health conditions (e.g., burnout, depression, anxiety)" takes the top spot, while "Deafness or hearing loss" is at the other end of the ranking.These results are based on a representative online survey conducted in 2025 among ****** consumers in the United States.

Snapshot img

US Population Health Management (PHM) Market Size 2025-2029

The us population health management (phm) market size is forecast to increase by USD 6.04 billion at a CAGR of 7.4% between 2024 and 2029.

The Population Health Management (PHM) market in the US is experiencing significant growth, driven by the increasing adoption of healthcare IT solutions and analytics. These technologies enable healthcare providers to collect, analyze, and act on patient data to improve health outcomes and reduce costs. However, the high perceived costs associated with PHM solutions pose a challenge for some organizations, limiting their ability to fully implement and optimize these technologies. Despite this obstacle, the potential benefits of PHM, including improved patient care and population health, make it a strategic priority for many healthcare organizations. To capitalize on this opportunity, companies must focus on cost-effective solutions and innovative approaches to addressing the challenges of PHM implementation and optimization. By leveraging advanced analytics, cloud technologies, and strategic partnerships, organizations can overcome cost barriers and deliver better care to their patient populations.

What will be the size of the US Population Health Management (PHM) Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The Population Health Management (PHM) market in the US is experiencing significant advancements, integrating various elements to improve patient outcomes and reduce healthcare costs. Public health surveillance and data governance ensure accurate population health data, enabling healthcare leaders to identify health disparities and target interventions. Quality measures and health literacy initiatives promote transparency and patient activation, while data visualization and business intelligence facilitate data-driven decision-making. Behavioral health integration, substance abuse treatment, and mental health services address the growing need for holistic care, and outcome-based contracts incentivize providers to focus on patient outcomes. Health communication, community health workers, and patient portals enhance patient engagement, while wearable devices and mHealth technologies provide real-time data for personalized care plans. Precision medicine and predictive modeling leverage advanced analytics to tailor treatment approaches, and social service integration addresses the social determinants of health. Health data management, data storytelling, and healthcare innovation continue to drive market growth, transforming the industry and improving overall population health.

How is this market segmented?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. ProductSoftwareServicesDeploymentCloudOn-premisesEnd-userHealthcare providersHealthcare payersEmployers and government bodiesGeographyNorth AmericaUS

By Product Insights

The software segment is estimated to witness significant growth during the forecast period.

Population Health Management (PHM) software in the US gathers patient data from healthcare systems and utilizes advanced analytics tools, including data visualization and business intelligence, to predict health conditions and improve patient care. PHM software aims to enhance healthcare efficiency, reduce costs, and ensure quality patient care. By analyzing accurate patient data, PHM software enables the identification of community health risks, leading to proactive interventions and better health outcomes. The adoption of PHM software is on the rise in the US due to the growing emphasis on value-based care and the increasing prevalence of chronic diseases. Machine learning, artificial intelligence, and predictive analytics are integral components of PHM software, enabling healthcare payers to develop personalized care plans and improve care coordination. Data integration and interoperability facilitate seamless data sharing among various healthcare stakeholders, while data visualization tools help in making informed decisions. Public health agencies and healthcare providers leverage PHM software for population health research, disease management programs, and quality improvement initiatives. Cloud computing and data warehousing provide the necessary infrastructure for storing and managing large volumes of population health data. Healthcare regulations mandate the adoption of PHM software to ensure compliance with data privacy and security standards. PHM software also supports care management services, patient engagement platforms, and remote patient monitoring, empowering patients

Snapshot img

Population Health Management Market Size 2025-2029

The population health management market size is forecast to increase by USD 19.40 billion at a CAGR of 10.7% between 2024 and 2029.

The Population Health Management Market is experiencing significant growth, driven by the increasing adoption of healthcare IT solutions and the rising focus on personalized medicine. The implementation of electronic health records (EHRs) and other digital health technologies has enabled healthcare providers to collect and analyze large amounts of patient data, facilitating proactive care and population health management. Moreover, the trend towards personalized medicine, which aims to tailor healthcare treatments to individual patients based on their unique genetic makeup and health history, is further fueling the demand for PHM solutions. However, the high cost of installing and implementing these platforms poses a significant challenge for market growth.
Despite this, the potential benefits of PHM, including improved patient outcomes, reduced healthcare costs, and enhanced population health, make it an attractive area for investment and innovation. Companies seeking to capitalize on these opportunities must navigate the challenges of data privacy and security, interoperability, and integration with existing healthcare systems. By addressing these challenges and focusing on delivering actionable insights from patient data, PHM solution providers can help healthcare organizations optimize their resources, improve patient care, and ultimately, improve population health.

What will be the Size of the Population Health Management Market during the forecast period?

Request Free Sample

The market is experiencing significant growth, driven by the increasing focus on accountable care organizations (ACOs) and payer organizations to improve health outcomes and reduce costs. Healthcare professionals are leveraging big data, data analytics services, and clinical data integration to develop personalized care plans and implement intervention strategies for various populations. Telehealth services have become essential in population health management, enabling care coordination, health promotion, and health navigation for patients. Health equity is a critical factor in population health management, with a growing emphasis on addressing disparities and ensuring equal access to care.
Data security and interoperability standards are essential in population health management, as healthcare providers exchange sensitive patient data for risk adjustment, care pathways, and quality reporting. Data mining and data visualization tools are used to identify health behavior changes and lifestyle modifications, leading to better health outcomes. Consumer health technology, such as patient engagement tools and wearable technology, are playing an increasingly important role in population health management. Health coaching and evidence-based medicine are intervention strategies used to prevent diseases and improve health outcomes. In summary, the market in the US is characterized by the adoption of precision medicine, health literacy, clinical guidelines, and personalized care plans.
The market is driven by the need for care coordination, data analytics, and patient engagement to improve health outcomes and reduce costs. The use of data security, data mining, and interoperability standards ensures the effective exchange and utilization of health data.

How is this Population Health Management Industry segmented?

The population health management industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Component

  Software
  Services


End-user

  Large enterprises
  SMEs


Delivery Mode

  On-Premise
  Cloud-Based
  Web-Based
  On-Premise
  Cloud-Based


End-Use

  Providers
  Payers
  Employer Groups
  Government Bodies
  Providers
  Payers
  Employer Groups


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World

By Component Insights

The software segment is estimated to witness significant growth during the forecast period.

The market's software segment is experiencing significant growth and innovation. Healthcare organizations are utilizing these solutions to effectively manage and enhance the health outcomes of diverse populations. The software component incorporates various tools that collect, analyze, and utilize health data for informed decision-making. Population health management platforms gather data from multiple sources, such as electronic health records, claims data, and patient-generated data. These platforms employ advanced analytics to generate valuable insi

The National Health Interview Survey (NHIS) is the principal source of information on the health of the civilian noninstitutionalized population of the United States and is one of the major data collection programs of the National Center for Health Statistics (NCHS) which is part of the Centers for Disease Control and Prevention (CDC). The National Health Survey Act of 1956 provided for a continuing survey and special studies to secure accurate and current statistical information on the amount, distribution, and effects of illness and disability in the United States and the services rendered for or because of such conditions. The survey referred to in the Act, now called the National Health Interview Survey, was initiated in July 1957. Since 1960, the survey has been conducted by NCHS, which was formed when the National Health Survey and the National Vital Statistics Division were combined. NHIS data are used widely throughout the Department of Health and Human Services (DHHS) to monitor trends in illness and disability and to track progress toward achieving national health objectives. The data are also used by the public health research community for epidemiologic and policy analysis of such timely issues as characterizing those with various health problems, determining barriers to accessing and using appropriate health care, and evaluating Federal health programs. The NHIS also has a central role in the ongoing integration of household surveys in DHHS. The designs of two major DHHS national household surveys have been or are linked to the NHIS. The National Survey of Family Growth used the NHIS sampling frame in its first five cycles and the Medical Expenditure Panel Survey currently uses half of the NHIS sampling frame. Other linkage includes linking NHIS data to death certificates in the National Death Index (NDI). While the NHIS has been conducted continuously since 1957, the content of the survey has been updated about every 10-15 years. In 1996, a substantially revised NHIS questionnaire began field testing. This revised questionnaire, described in detail below, was implemented in 1997 and has improved the ability of the NHIS to provide important health information.

Introduction

Global Big Data in Healthcare Market size is expected to be worth around USD 145.8 Billion by 2033 from USD 42.2 Billion in 2023, growing at a CAGR of 13.2% during the forecast period from 2024 to 2033.

Big data in healthcare encompasses vast amounts of diverse, unstructured data sourced from medical journals, biometric sensors, electronic medical records (EMRs), Internet of Medical Things (IoMT), social media platforms, payer records, omics research, and data repositories. Integrating this unstructured data into traditional systems presents considerable challenges, primarily in data structuring and standardization. Effective data structuring is essential for ensuring compatibility across systems and enabling robust analytical processes.

However, advancements in big data analytics, artificial intelligence, and machine learning have significantly enhanced the ability to convert complex healthcare data into actionable insights. These advancements have transformed healthcare, driving informed decision-making, enabling early and accurate diagnostics, facilitating precision medicine, and enhancing patient engagement through digital self-service platforms, including online portals, mobile applications, and wearable health devices.

The role of big data in pharmaceutical R&D has become increasingly central, as analytics tools streamline drug discovery, accelerate clinical trial processes, and identify potential therapeutic targets more efficiently. The demand for business intelligence solutions within healthcare is rising, fueled by the surge of unstructured data and the focus on developing tailored treatment protocols. As a result, the global market for big data in healthcare is projected to grow steadily during the forecast period.

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases among people who received additional or booster doses were reported from 31 jurisdictions; 30 jurisdictions also reported data on deaths among people who received one or more additional or booster dose; 28 jurisdictions reported cases among people who received two or more additional or booster doses; and 26 jurisdictions reported deaths among people who received two or more additional or booster doses. This list will be updated as more jurisdictions participate. Incidence rate estimates: Weekly age-specific incidence rates by vaccination status were calculated as the number of cases or deaths divided by the number of people vaccinated with a primary series, overall or with/without a booster dose (cumulative) or unvaccinated (obtained by subtracting the cumulative number of people vaccinated with a primary series and partially vaccinated people from the 2019 U.S. intercensal population estimates) and multiplied by 100,000. Overall incidence rates were age-standardized using the 2000 U.S. Census standard population. To estimate population counts for ages 6 months through 1 year, half of the single-year population counts for ages 0 through 1 year were used. All rates are plotted by positive specimen collection date to reflect when incident infections occurred. For the primary series analysis, age-standardized rates include ages 12 years and older from April 4, 2021 through December 4, 2021, ages 5 years and older from December 5, 2021 through July 30, 2022 and ages 6 months and older from July 31, 2022 onwards. For the booster dose analysis, age-standardized rates include ages 18 years and older from September 19, 2021 through December 25, 2021, ages 12 years and older from December 26, 2021, and ages 5 years and older from June 5, 2022 onwards. Small numbers could contribute to less precision when calculating death rates among some groups. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage. Incidence rate ratios (IRRs): IRRs for the past one month were calculated by dividing the average weekly incidence rates among unvaccinated people by that among people vaccinated with a primary series either overall or with a booster dose. Publications: Scobie HM, Johnson AG, Suthar AB, et al. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1284–1290. Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71:132–138. Johnson AG, Linde L, Ali AR, et al. COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022. MMWR Morb Mortal Wkly Rep 2023;72:145–152. Johnson AG, Linde L, Payne AB, et al. Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months — 20 U.S. Jurisdictions, September 18, 2022–April 1, 2023. MMWR Morb Mortal Wkly Rep 2023;72:667–669.

This dataset contains model-based census tract estimates. PLACES covers the entire United States—50 states and the District of Columbia—at county, place, census tract, and ZIP Code Tabulation Area levels. It provides information uniformly on this large scale for local areas at four geographic levels. Estimates were provided by the Centers for Disease Control and Prevention (CDC), Division of Population Health, Epidemiology and Surveillance Branch. PLACES was funded by the Robert Wood Johnson Foundation in conjunction with the CDC Foundation. The dataset includes estimates for 40 measures: 12 for health outcomes, 7 for preventive services use, 4 for chronic disease-related health risk behaviors, 7 for disabilities, 3 for health status, and 7 for health-related social needs. These estimates can be used to identify emerging health problems and to help develop and carry out effective, targeted public health prevention activities. Because the small area model cannot detect effects due to local interventions, users are cautioned against using these estimates for program or policy evaluations. Data sources used to generate these model-based estimates are Behavioral Risk Factor Surveillance System (BRFSS) 2022 or 2021 data, Census Bureau 2020 population data, and American Community Survey 2018–2022 estimates. The 2024 release uses 2022 BRFSS data for 36 measures and 2021 BRFSS data for 4 measures (high blood pressure, high cholesterol, cholesterol screening, and taking medicine for high blood pressure control among those with high blood pressure) that the survey collects data on every other year. More information about the methodology can be found at www.cdc.gov/places.

Women's Health Market Overview

Women's health encompasses various medical and wellness concerns unique to females throughout their lives.

This includes matters related to reproductive health, pregnancy, and childbirth, and the management of conditions such as breast cancer, gynecological issues, menopause, and hormonal imbalances.

Additionally, women's health well-being encompasses mental health, dietary considerations, and overall physical health.

Key components involve regular health check-ups, ensuring access to contraception, and providing family planning services.

The promotion of women's health involves the dissemination of knowledge, early identification of health problems, and tailoring of healthcare interventions to empower women to lead healthy lives while enabling them to make well-informed decisions concerning their bodies and reproductive choices.

As of August 2024, some 20 percent of Americans surveyed were of the opinion that opioids and fentanyl addiction is the number one public health threat in the U.S., a significant decrease from 24 percent in June 2024. Furthermore, obesity was viewed as a top public health issue by 19 percent of Americans in August 2024.
U.S. healthcare issues The United States has the highest healthcare spending globally. The majority of Americans considered rising healthcare costs as the most important healthcare problem facing the U.S. in January 2023. While COVID-19 and cancer were ranked second on the list. Due to unfortunate mass shooting incidents in the country, gun violence is typically related to homicide and is not considered a healthcare issue. Although the most popular method of suicide among Americans who attempted it was a gun or firearm, the link between gun access and suicide is frequently ignored as a public health crisis.

The global women's health market is predicted to reach a value of XXX million by 2033, with a CAGR of XX% during the forecast period (2025-2033). The market is driven by factors such as the rising prevalence of chronic diseases among women, increased awareness of women's health issues, and the growing demand for personalized and tailored healthcare solutions. Key trends in the market include the increasing adoption of telemedicine and digital health technologies, the growing focus on preventive care, and the development of innovative therapies and treatments for women's health conditions. The market is segmented based on application, type, and region. The major applications of women's health products and services include contraception, fertility treatments, prenatal care, gynecological care, and menopause management. The different types of products and services available in the market include pharmaceuticals, devices, diagnostics, and treatments. Regionally, the market is segmented into North America, South America, Europe, the Middle East & Africa, and Asia Pacific. North America is the largest market for women's health products and services, followed by Europe and Asia Pacific. The Middle East & Africa and South America are expected to witness significant growth in the coming years due to the increasing prevalence of chronic diseases among women and the rising demand for healthcare services.